Bayer powers Versant cell therapy startup to $250M round

Bayer powers Versant cell therapy startup to $250M round

Source: 
Fierce Biotech
snippet: 

Versant Ventures’ Century Therapeutics has exited stealth with $250 million to take allogeneic cell therapies into the clinic. Bayer’s VC wing led the investment with the support of Versant and Fujifilm Cellular Dynamics.